Skip to content

Comparison of remazolam and propofol for painless colonoscopy

Comparison of remazolam and propofol for painless colonoscopy: a randomized, double-blind trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048678
Enrollment
Unknown
Registered
2021-07-12
Start date
2021-07-11
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Interventions

Remimazolam group:Remazolam combined with sufentanil anesthesia
Propofol group:Propofol combined with sufentanil anesthesia

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Adult patients undergoing elective painless colonoscopy; 2.American Society of Anesthesiologists (ASA) Level I-II; 3.Aged 18 to 65 years.

Exclusion criteria

Exclusion criteria: 1.BMI >30 kg/m^2; 3.Allergies to study drugs; 3.Pregnant women with limited walking ability; 4.Taking benzodiazepines or opioids within 24 hours before the examination; 5.They are not suitable for the study for any reason, such as language comprehension difficulties, cognitive impairment or mental illness, or patients' refusal to participate.

Design outcomes

Primary

MeasureTime frame
The time at which discharge criteria are reached;

Secondary

MeasureTime frame
Time of operation;The degree of anesthesia recovery was monitored in the treatment room after anesthesia;Incidence of hypoxemia;Induction time of anesthesia;Incidence of hypotension;Weight;

Countries

China

Contacts

Public ContactYao Yusheng

Fujian Medical University

fjslyys@126.com+86 13559939629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026